SCHEMBL5906823

SCHEMBL5906823

COC(=O)[C@H](Cc1ccccc1)Nc1nccc(-c2ccc(NS(=O)(=O)c3ccccc3)cc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 4/20 0.44
LMNA P02545 3/20 0.44
IKBKB O14920 3/20 0.44
KMT2A Q03164 3/20 0.44
MAPT P10636 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MEN1 O00255 2/20 0.44
HDAC1 Q13547 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
NPR3 P17342 2/20 0.42
CNR1 P21554 1/20 0.42
HTT P42858 1/20 0.42
JAK2 O60674 1/20 0.41
JAK3 P52333 1/20 0.41
TACR3 P29371 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5906821 1.00 ALDH1A1 (0.47) ALDH1A1KDM4ELMNAIKBKBKMT2A
SCHEMBL5906911 0.91 ALDH1A1 (0.48) ALDH1A1KDM4ELMNAIKBKBKMT2A
SCHEMBL5906906 0.91 ALDH1A1 (0.48) ALDH1A1KDM4ELMNAIKBKBKMT2A
SCHEMBL5906787 0.82 CLK1 (0.47) ALDH1A1KDM4EIKBKBKMT2AMEN1
SCHEMBL5906791 0.82 CLK1 (0.47) ALDH1A1KDM4EIKBKBKMT2AMEN1
SCHEMBL5906647 0.82 DYRK1A (0.45) HDAC1NPR3JAK2JAK3TACR3
SCHEMBL5906648 0.82 DYRK1A (0.45) HDAC1NPR3JAK2JAK3TACR3
SCHEMBL5906859 0.82 NOS2 (0.47) HDAC1JAK2JAK3TACR3
SCHEMBL5906845 0.81 KMO (0.45) ALDH1A1KDM4ELMNAKMT2AMAPT
SCHEMBL5906849 0.81 KMO (0.45) ALDH1A1KDM4ELMNAKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060089371-A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist BAYER HEALTHCARE AG (DE) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089371-A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist BPHL, HRH4, HRH2 ALDH1A1 655/4885KDM4E 1339/4885LMNA 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.